PDB Short entry for 1M4E
HEADER    ANTIMICROBIAL PROTEIN                   02-JUL-02   1M4E              
TITLE     SOLUTION STRUCTURE OF HEPCIDIN-20                                     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HEPCIDIN;                                                  
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: HEPCIDIN-20 (RESIDUES 65-84);                              
COMPND   5 SYNONYM: LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE, LEAP-1,              
COMPND   6 PUTATIVE LIVER TUMOR REGRESSOR, PLTR, HEPC20;                        
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 OTHER_DETAILS: THE SEQUENCE OF THE PROTEIN IS NATURALLY              
SOURCE   4 FOUND IN HOMO SAPIENS. THE PROTEIN WAS CHEMICALLY                    
SOURCE   5 SYNTHESIZED.                                                         
KEYWDS    STRAND-LOOP-STRAND, BETA-SHEET, HAIRPIN LOOP, ANTIMICROBIAL           
KEYWDS   2 PROTEIN                                                              
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    H.N.HUNTER,D.B.FULTON,T.GANZ,H.J.VOGEL                                
REVDAT   2   24-FEB-09 1M4E    1       VERSN                                    
REVDAT   1   06-NOV-02 1M4E    0                                                
JRNL        AUTH   H.N.HUNTER,D.B.FULTON,T.GANZ,H.J.VOGEL                       
JRNL        TITL   THE SOLUTION STRUCTURE OF HUMAN HEPCIDIN, A                  
JRNL        TITL 2 PEPTIDE HORMONE WITH ANTIMICROBIAL ACTIVITY THAT             
JRNL        TITL 3 IS INVOLVED IN IRON UPTAKE AND HEREDITARY                    
JRNL        TITL 4 HEMOCHROMATOSIS.                                             
JRNL        REF    J.BIOL.CHEM.                  V. 277 37597 2002              
JRNL        REFN                   ISSN 0021-9258                               
JRNL        PMID   12138110                                                     
JRNL        DOI    10.1074/JBC.M205305200                                       
REMARK   1                                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.1                                              
REMARK   3   AUTHORS     : BRUNGER ET AL                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON 285 NOE-      
REMARK   3  DERIVED DISTANCE CONSTRAINTS, 17 DIHEDRAL ANGLE RESTRAINTS, 5       
REMARK   3  DISTANCE RESTRAINTS FROM HYDROGEN BONDS.                            
REMARK   4                                                                      
REMARK   4 1M4E COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUL-02.                  
REMARK 100 THE RCSB ID CODE IS RCSB016583.                                      
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 3.2                                
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 0.78MM HEPCIDIN-20                 
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D NOESY, 2D TOCSY, 13C-HSQC,      
REMARK 210                                   DIFFUSION                          
REMARK 210  SPECTROMETER FIELD STRENGTH    : 500 MHZ, 700 MHZ                   
REMARK 210  SPECTROMETER MODEL             : AVANCE                             
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : XWINNMR 2.6, CNS 1.1, NMRPIPE      
REMARK 210                                   3.4                                
REMARK 210   METHOD USED                   : SIMULATED ANNEALING,               
REMARK 210                                   MOLECULAR DYNAMICS, MATRIX         
REMARK 210                                   RELAXATION, TORSION ANGLE          
REMARK 210                                   DYNAMICS                           
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 100                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D              
REMARK 210  HOMONUCLEAR TECHNIQUES.                                             
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 ILE A   3       96.45    -69.98                                   
REMARK 500  1 PHE A   4      106.07    -50.34                                   
REMARK 500  1 CYS A   9      -56.35   -129.28                                   
REMARK 500  1 HIS A  10     -137.96    -73.35                                   
REMARK 500  1 CYS A  18       55.08    -90.15                                   
REMARK 500  2 PHE A   4       93.14    -45.18                                   
REMARK 500  2 CYS A   9      -55.45   -129.04                                   
REMARK 500  2 HIS A  10     -137.17    -81.88                                   
REMARK 500  2 CYS A  18       51.37   -102.60                                   
REMARK 500  3 PHE A   4       91.61    -43.96                                   
REMARK 500  3 CYS A   9      -54.72   -129.14                                   
REMARK 500  3 HIS A  10     -136.88    -80.04                                   
REMARK 500  4 PHE A   4       99.33    -44.52                                   
REMARK 500  4 CYS A   9      -54.97   -129.37                                   
REMARK 500  4 HIS A  10     -135.66    -75.81                                   
REMARK 500  5 ILE A   3       96.64    -68.92                                   
REMARK 500  5 PHE A   4       99.69    -49.68                                   
REMARK 500  5 CYS A   6       59.85    -90.39                                   
REMARK 500  5 CYS A   9      -55.87   -128.71                                   
REMARK 500  5 HIS A  10     -132.30    -77.37                                   
REMARK 500  5 CYS A  18       49.75   -105.76                                   
REMARK 500  6 PHE A   4       93.24    -44.26                                   
REMARK 500  6 CYS A   9      -52.78   -128.93                                   
REMARK 500  6 HIS A  10     -142.01    -73.46                                   
REMARK 500  6 CYS A  18       52.03    -98.79                                   
REMARK 500  6 LYS A  19       56.87   -110.67                                   
REMARK 500  7 PHE A   4      106.12    -46.34                                   
REMARK 500  7 CYS A   9      -58.08   -129.46                                   
REMARK 500  7 HIS A  10     -128.88    -75.80                                   
REMARK 500  8 PHE A   4      102.79    -50.27                                   
REMARK 500  8 CYS A   6       58.14    -91.18                                   
REMARK 500  8 CYS A   9      -64.82   -129.21                                   
REMARK 500  8 HIS A  10     -122.76    -84.07                                   
REMARK 500  9 PHE A   4       98.99    -50.89                                   
REMARK 500  9 CYS A   9      -57.13   -129.60                                   
REMARK 500  9 HIS A  10     -130.45    -79.63                                   
REMARK 500  9 LYS A  19      -45.09    -29.86                                   
REMARK 500 10 PHE A   4      105.46    -47.52                                   
REMARK 500 10 CYS A   9      -66.23   -128.64                                   
REMARK 500 10 HIS A  10      -52.95   -120.84                                   
REMARK 500 11 PHE A   4      104.89    -50.54                                   
REMARK 500 11 CYS A   9      -56.63   -129.23                                   
REMARK 500 11 HIS A  10     -137.15    -74.64                                   
REMARK 500 11 LYS A  19      135.19    -32.08                                   
REMARK 500 12 ILE A   3       97.39    -66.85                                   
REMARK 500 12 PHE A   4      104.65    -49.74                                   
REMARK 500 12 CYS A   9      -54.31   -128.96                                   
REMARK 500 12 HIS A  10     -138.57    -75.26                                   
REMARK 500 13 ILE A   3       98.52    -61.56                                   
REMARK 500 13 PHE A   4       94.66    -53.09                                   
REMARK 500 13 CYS A   9      -55.50   -129.05                                   
REMARK 500 13 HIS A  10     -140.21    -74.87                                   
REMARK 500 14 PHE A   4      105.18    -47.78                                   
REMARK 500 14 CYS A   8      -73.95    -66.77                                   
REMARK 500 14 HIS A  10     -128.71    -74.76                                   
REMARK 500 15 PHE A   4      106.78    -47.88                                   
REMARK 500 15 CYS A   9      -53.36   -128.70                                   
REMARK 500 15 HIS A  10     -142.22    -73.15                                   
REMARK 500 15 LYS A  19      153.02    -49.88                                   
REMARK 500 16 ILE A   3       97.63    -62.71                                   
REMARK 500 16 PHE A   4      104.95    -50.76                                   
REMARK 500 16 CYS A   8      -75.12    -74.32                                   
REMARK 500 16 HIS A  10     -137.11    -71.96                                   
REMARK 500 17 PHE A   4      105.89    -46.93                                   
REMARK 500 17 CYS A   9      -56.80   -129.22                                   
REMARK 500 17 HIS A  10     -139.74    -74.98                                   
REMARK 500 18 ILE A   3       96.96    -67.52                                   
REMARK 500 18 PHE A   4      107.61    -48.83                                   
REMARK 500 18 CYS A   9      -56.52   -128.84                                   
REMARK 500 18 HIS A  10     -141.01    -73.27                                   
REMARK 500 19 ILE A   3       97.73    -62.96                                   
REMARK 500 19 PHE A   4      107.36    -49.46                                   
REMARK 500 19 CYS A   9      -64.75   -128.91                                   
REMARK 500 19 HIS A  10     -135.13    -80.61                                   
REMARK 500 20 ILE A   3       97.77    -62.67                                   
REMARK 500 20 PHE A   4      100.38    -52.13                                   
REMARK 500 20 CYS A   9      -62.49   -129.47                                   
REMARK 500 20 HIS A  10     -126.77    -79.43                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1M4F   RELATED DB: PDB                                   
REMARK 900 THE SOLUTION STRUCTURE OF HEPCIDIN-25                                
DBREF  1M4E A    1    20  UNP    P81172   HEPC_HUMAN      65     84             
SEQRES   1 A   20  ILE CYS ILE PHE CYS CYS GLY CYS CYS HIS ARG SER LYS          
SEQRES   2 A   20  CYS GLY MET CYS CYS LYS THR                                  
SHEET    1   A 2 ILE A   3  CYS A   6  0                                        
SHEET    2   A 2 CYS A  14  CYS A  17 -1  O  GLY A  15   N  CYS A   5           
SSBOND   1 CYS A    2    CYS A   18                          1555   1555  2.03  
SSBOND   2 CYS A    5    CYS A   17                          1555   1555  2.03  
SSBOND   3 CYS A    6    CYS A   14                          1555   1555  2.03  
SSBOND   4 CYS A    8    CYS A    9                          1555   1555  2.09  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000